BiotechTube

Sugammadex 100 MG/ML [Bridion]

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Respiratory Complication

Conditions

Respiratory Complication, Obstructive Sleep Apnea

Trial Timeline

Feb 18, 2022 → May 7, 2025

NCT ID
NCT04263363

About Sugammadex 100 MG/ML [Bridion]

Sugammadex 100 MG/ML [Bridion] is a approved stage product being developed by Merck for Respiratory Complication. The current trial status is completed. This product is registered under clinical trial identifier NCT04263363. Target conditions include Respiratory Complication, Obstructive Sleep Apnea.

What happened to similar drugs?

9 of 20 similar drugs in Respiratory Complication were approved

Approved (9) Terminated (3) Active (10)
✅Zopapogene imadenovec (Zopa)PrecigenApproved
✅YMC026 + PlaceboYuhanApproved
✅Montelukast + PlaceboMerckApproved
✅diclofenac potassium + nimesulideNovartisApproved
✅Bacterial Lysates + placeboSanofiApproved
✅Telithromycin + AzithromycinSanofiApproved
✅telithromycinSanofiApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT04263363ApprovedCompleted

Competing Products

20 competing products in Respiratory Complication

See all competitors
ProductCompanyStageHype Score
mRNA-1273ModernaPhase 1
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPhase 1
0
mRNA-1345ModernaPhase 2
0
mRNA-1345ModernaPhase 2
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPreclinical
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPhase 3
0
mRNA-1345ModernaPhase 1
0
Zopapogene imadenovec (Zopa)PrecigenApproved
44
PRGN-2012 - Phase I; Dose Level 1 + PRGN-2012 - Phase I; Dose Level 2 + PRGN-2012 - Phase II; Dose Level 2PrecigenPhase 1/2
30
agenT-797MiNK TherapeuticsPhase 1
19
YMC026 + PlaceboYuhanApproved
43
VN-0200 + PlaceboDaiichi SankyoPhase 1
29
VN-0200Daiichi SankyoPhase 2
35
Isavuconazonium Injection [Cresemba] + PlaceboAstellas PharmaPhase 3
32
S-337395 + PlaceboShionogiPhase 2
42
SivelestatEli LillyPhase 1/2
32